PubRank
Search
About
Ingrid Hilger
Author PubWeight™ 30.15
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Magnetic multicore nanoparticles for hyperthermia--influence of particle immobilization in tumour tissue on magnetic properties.
Nanotechnology
2011
1.49
2
Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model.
Crit Care
2013
1.29
3
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis.
PLoS Med
2012
1.27
4
High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area.
Pharm Res
2014
1.03
5
In vivo imaging of experimental arthritis with near-infrared fluorescence.
Arthritis Rheum
2004
1.02
6
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
Phys Med Biol
2009
0.93
7
Diagnosis of arthritis using near-infrared fluorochrome Cy5.5.
Invest Radiol
2004
0.93
8
Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model.
Radiology
2002
0.92
9
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.
Radiology
2008
0.91
10
Minimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in mice.
Nanotechnology
2011
0.91
11
Bioelectromagnetic field effects on cancer cells and mice tumors.
Electromagn Biol Med
2010
0.89
12
An in vitro characterization study of new near infrared dyes for molecular imaging.
Eur J Med Chem
2009
0.88
13
Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents.
Invest Radiol
2007
0.88
14
Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice.
Small
2008
0.87
15
Suitable labels for molecular imaging--influence of dye structure and hydrophilicity on the spectroscopic properties of IgG conjugates.
Bioconjug Chem
2011
0.86
16
The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.
Int J Nanomedicine
2013
0.85
17
Can we accurately quantify nanoparticle associated proteins when constructing high-affinity MRI molecular imaging probes?
Contrast Media Mol Imaging
2011
0.85
18
A robust optical respiratory trigger for small rodents in clinical whole-body MR systems.
Biomed Tech (Berl)
2008
0.84
19
Controlled modulation of serum protein binding and biodistribution of asymmetric cyanine dyes by variation of the number of sulfonate groups.
Mol Imaging
2011
0.83
20
Multifactorial diagnostic NIR imaging of CCK2R expressing tumors.
Biomaterials
2013
0.83
21
Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo.
Small
2013
0.82
22
Diagnosis of peritonitis using near-infrared optical imaging of in vivo labeled monocytes-macrophages.
J Biomed Opt
2007
0.81
23
Multiplexed in vivo fluorescence optical imaging of the therapeutic efficacy of photodynamic therapy.
Biomaterials
2013
0.80
24
Novel fluorophores as building blocks for optical probes for in vivo near infrared fluorescence (NIRF) imaging.
J Fluoresc
2010
0.80
25
Optical imaging of CCK₂/gastrin receptor-positive tumors with a minigastrin near-infrared probe.
Invest Radiol
2011
0.79
26
Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin.
J Heart Lung Transplant
2013
0.79
27
Noninvasive diagnosis of arthritis by autofluorescence.
Invest Radiol
2003
0.79
28
Determination of the labeling density of fluorophore-biomolecule conjugates with absorption spectroscopy.
Bioconjug Chem
2012
0.78
29
Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer's disease models.
J Med Chem
2012
0.77
30
Means to increase the therapeutic efficiency of magnetic heating of tumors.
Biomed Tech (Berl)
2015
0.77
31
Assessment of rat antigen-induced arthritis and its suppression during glucocorticoid therapy by use of hemicyanine dye probes with different molecular weight in near-infrared fluorescence optical imaging.
Invest Radiol
2013
0.77
32
Proliferating and quiescent human umbilical vein endothelial cells (HUVECs): a potential in vitro model to evaluate contrast agents for molecular imaging of angiogenesis.
Contrast Media Mol Imaging
2009
0.77
33
Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.
EJNMMI Res
2013
0.77
34
Autofluorescence spectroscopy in whole organs with a mobile detector system.
Acad Radiol
2004
0.75
35
Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer's disease brains.
Bioorg Med Chem
2013
0.75
36
Design, synthesis and biological evaluation of trimethine cyanine dyes as fluorescent probes for the detection of tau fibrils in Alzheimer's disease brain and olfactory epithelium.
ChemMedChem
2013
0.75
37
Sugar-selective enrichment of a D-glucose-substituted ruthenium bipyridyl complex inside HepG2 cancer cells.
Chembiochem
2010
0.75
38
2-Styrylindolium based fluorescent probes visualize neurofibrillary tangles in Alzheimer's disease.
Bioorg Med Chem Lett
2012
0.75
39
Magnetic nanoparticles adapted for specific biomedical applications.
Biomed Tech (Berl)
2015
0.75
40
Formation of magnetic aluminium oxyhydroxide nanorods and use for hyperthermal effects.
Nanotechnology
2011
0.75
41
Detection of leukotriene receptor CysLT1R in inflammatory diseases by molecular imaging with near-infrared fluorescence-based contrast agents.
Mol Imaging
2011
0.75
42
An in vivo spectral multiplexing approach for the cooperative imaging of different disease-related biomarkers with near-infrared fluorescent forster resonance energy transfer probes.
J Nucl Med
2012
0.75